Big pharma, Partnering, Pharma

Novartis announces biotech partnering with Google

Posted on 16 July 2014

Tags: , , ,

Novartis has entered into a biotech partnering agreement with a division of Google to in-license its "smart lens" technology for all ocular medical uses.

The agreement with Google provides Alcon with the opportunity to develop and commercialize Google's "smart lens" technology with the potential to transform eye care and further enhance Alcon's pipeline and global leadership in contact lenses and intraocular lenses.

The transaction remains subject to anti-trust approvals.

The agreement between Google and Alcon represents an important step for Novartis, across all of its divisions, to leverage technology to manage human diseases and conditions.

Google's key advances in the miniaturization of electronics complement Novartis's deep pharmaceuticals and medical device expertise.

Novartis aims to enhance the ways in which diseases are mapped within the body and ultimately prevented.

Google and Alcon will collaborate to develop a "smart lens" that has the potential to address ocular conditions.

The smart lens technology involves non-invasive sensors, microchips and other miniaturized electronics which are embedded within contact lenses.

Novartis' interest in this technology is currently focused in two areas:

  1. Helping diabetic patients manage their disease by providing a continuous, minimally invasive measurement of the body's glucose levels via a "smart contact lens" which is designed to measure tear fluid in the eye and connects wirelessly with a mobile device;
  2. For people living with presbyopia who can no longer read without glasses, the "smart lens" has the potential to provide accommodative vision correction to help restore the eye's natural autofocus on near objects in the form of an accommodative contact lens or intraocular lens as part of the refractive cataract treatment.

The agreement marries Google's expertise in miniaturized electronics, low power chip design and microfabrication with Alcon's expertise in physiology and visual performance of the eye, clinical development and evaluation, as well as commercialization of contact and intraocular lenses.

Through the collaboration, Alcon seeks to accelerate product innovation based on Google's "smart lens" technology.

For further deal information visit Current Agreements (subscription required)

Related

Report: Partnering Deals and Alliances with Novartis

Browse: Complete Current Partnering report catalog

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply

 

cpbannerad300x150new1gif
rauconbadgejpg
e80banner300x150animgif
cpbannerad300x150new1gif
rauconbadgejpg
a1banner300x150animgif